According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is -1,35ย โฌ. In 2025 the company made an earnings per share (EPS) of -1,73ย โฌ an increase over its 2024 EPS that were of -2,08ย โฌ.